Literature DB >> 658110

Effect of aminoglycosides on proximal tubular membranes of the human kidney.

A W Mondorf, J Breier, J Hendus, J E Scherberich, G Mackenrodt, P M Shah, W Stille, W Schoeppe.   

Abstract

The effect of the aminoglycosides amikacin, gentamicin, netilmicin sisomicin and tobramycin on the proximal tubule of the human kidney was investigated in 78 healthy subjects. Fifteen adults were each given gentamicin, sisomicin or tobramycin 3 mg/kg bodyweight, 10 subjects received netilmicin 3 mg/kg or amikacin 15 mg/kg additionally seven subjects amikacin 10 mg and six subjects netilmicin 6 mg on three consecutive days. The principal enzyme of the brush border membrane of the proximal tubule, alanine aminopeptidase (AAP), was determined enzymatically and immunologically in 24-hour urines. The effects of the various aminoglycosides on the membranes were different. Less of membrane AAP was greatest after amikacin and was least after tobramycin. There was no difference between gentamicin, netilmicin, and sisomicin, which had an effect intermediate between the other two compounds. The elimination of AAP occurred at intervals which might possibly have been caused by impairment of cell cycles.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 658110     DOI: 10.1007/BF00609758

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  18 in total

1.  Gentamicin: toxicity in perspective.

Authors:  W L Hewitt
Journal:  Postgrad Med J       Date:  1974-11       Impact factor: 2.401

2.  Nephrotoxicity of aminoglycosides and gentamicin.

Authors:  F G Falco; H M Smith; G M Arcieri
Journal:  J Infect Dis       Date:  1969 Apr-May       Impact factor: 5.226

3.  Letter: Renal damage caused by gentamicin.

Authors:  J M Wellwood; D Lovell; A E Thompson; J R Tighe
Journal:  Br Med J       Date:  1974-06-15

4.  Nephrotoxicity of gentamicin.

Authors:  J C Kosek; R I Mazze; M J Cousins
Journal:  Lab Invest       Date:  1974-01       Impact factor: 5.662

5.  [Acute renal failure during treatment with gentamicin and cephalothin].

Authors:  D Kleinknecht; P Jungers
Journal:  Nouv Presse Med       Date:  1973-01-06

6.  [Acute renal failure following gentamicin-cephalosporin association therapy].

Authors:  A Opitz; I Herrmann; D van Herrath; K Schaefer
Journal:  Med Welt       Date:  1971-03-13

7.  Evidence of gentamicin nephrotoxicity in patients with renal allografts.

Authors:  J M Wellwood; P M Simpson; J R Tighe; A E Thompson
Journal:  Br Med J       Date:  1975-08-02

8.  Biochemical and immunological studies on isolated brush border membranes of human kidney cortex and their membrane surface proteins.

Authors:  J E Scherberich; F W Falkenberg; A W Mondorf; H Müller; G Pfleiderer
Journal:  Clin Chim Acta       Date:  1974-09-16       Impact factor: 3.786

9.  Quantitative estimation of proteins by electrophoresis in agarose gel containing antibodies.

Authors:  C B Laurell
Journal:  Anal Biochem       Date:  1966-04       Impact factor: 3.365

10.  [Alanine aminopeptidase and creatinine excretion under various conditions of diuresis in man].

Authors:  U Burchardt; A Hempel; J B Höpfner; R D Hempel
Journal:  Z Gesamte Inn Med       Date:  1976-07-15
View more
  15 in total

1.  Pharmacokinetics and antibacterial activity of daily gentamicin.

Authors:  H Skopnik; R Wallraf; B Nies; K Tröster; G Heimann
Journal:  Arch Dis Child       Date:  1992-01       Impact factor: 3.791

2.  Induction of light hydrocarbon nephropathy by p-dichlorobenzene.

Authors:  E Bomhard; G Luckhaus; W H Voigt; E Loeser
Journal:  Arch Toxicol       Date:  1988       Impact factor: 5.153

3.  Investigation on renal tolerability of ciprofloxacin with tests based on monoclonal antibodies.

Authors:  F W Falkenberg; A W Mondorf
Journal:  Infection       Date:  1988       Impact factor: 3.553

Review 4.  Assessment of nephrotoxicity.

Authors:  L F Prescott
Journal:  Br J Clin Pharmacol       Date:  1982-03       Impact factor: 4.335

5.  Human pharmacology of cefotaxime (HR 756), a new cephalosporin.

Authors:  R Lüthy; R Münch; J Blaser; H Bhend; W Siegenthaler
Journal:  Antimicrob Agents Chemother       Date:  1979-08       Impact factor: 5.191

6.  Tobramycin nephrotoxicity: failure of cefotaxime to potentiate renal toxicity.

Authors:  J Kuhlmann; G Seidel; H Grötsch
Journal:  Infection       Date:  1982       Impact factor: 3.553

7.  Assessment of renal function during high-dose cis-platinum therapy in patients with ovarian carcinoma.

Authors:  P K Buamah; A Howell; H Whitby; E S Harpur; A Gescher
Journal:  Cancer Chemother Pharmacol       Date:  1982       Impact factor: 3.333

8.  Renal tubular enzyme effects of clarithromycin in comparison with gentamicin and placebo in volunteers.

Authors:  M C Chapelsky; D E Nix; J C Cavanaugh; J H Wilton; A Norman; J J Schentag
Journal:  Drug Saf       Date:  1992 Jul-Aug       Impact factor: 5.606

9.  Urinary alanine aminopeptidase and beta 2-microglobulin as measurements of aminoglycoside-associated renal impairment.

Authors:  B Trollfors; J Bergmark; K Hiesche; R Jagenburg
Journal:  Infection       Date:  1984 Jan-Feb       Impact factor: 3.553

10.  Renal function in cystic fibrosis: proteinuria and enzymuria before and after tobramycin therapy.

Authors:  G Steinkamp; M Lütge; U Wurster; J G Schulz-Baldes; H J Gröne; J H Ehrich
Journal:  Eur J Pediatr       Date:  1986-12       Impact factor: 3.183

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.